Guidelines for the Diagnosis and Treatment of Hidradenitis Suppurativa in the UAE: A Consensus from the Emirates Dermatology Society - Summary - MDSpire

Guidelines for the Diagnosis and Treatment of Hidradenitis Suppurativa in the UAE: A Consensus from the Emirates Dermatology Society

  • By

  • Ahmed Ameen

  • Fatima Albreiki

  • Ayman Alnaeem

  • Muna Al Murrawi

  • Huda R. Ali

  • Raghda Almaashari

  • Fatima AL-Marzooqi

  • Jawaher Alnaqbi

  • Hussein A. Dayem

  • Mohamed Ahmed

  • Waqas Saad

  • Srikumar Goturu

  • Samir Hantirah

  • Ashraf Reda

  • Christos C. Zouboulis

  • February 17, 2026

  • 0 min

Share

Objective:

To provide region-specific guidelines for the diagnosis and management of hidradenitis suppurativa (HS) in the UAE, addressing its significant impact on patient quality of life.

Key Findings:
  • HS is a chronic inflammatory condition affecting the pilosebaceous unit, primarily in apocrine gland-bearing areas.
  • The prevalence of HS is challenging to estimate due to misdiagnosis and underdiagnosis, with significant implications for patient care.
  • HS significantly impacts patients' quality of life and is associated with mental health issues, necessitating comprehensive management strategies.
Interpretation:

The guidelines aim to standardize HS care in the UAE, addressing regional disparities and improving treatment outcomes through evidence-based clinical pathways, ultimately enhancing patient quality of life.

Limitations:
  • The consensus may not fully reflect all local variations in HS presentation and management, and potential biases in expert selection could affect the consensus.
  • Limited data on HS prevalence and burden in the UAE may affect the applicability of the guidelines.
Conclusion:

The consensus provides a structured approach to HS management in the UAE, aiming to enhance care quality and patient outcomes, with an emphasis on the importance of multidisciplinary care.

Original Source(s)

Related Content